Clinical Trial Update: Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based Setting [NA]

View source ↗

Summary

A hospital-based clinical trial is evaluating oseltamivir and baloxavir marboxil for preventing influenza, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nosocomial Infection

Drugs mentioned

• Tamiflu (oseltamivir)
• XOFLUZA (baloxavir marboxil)

Snippet

Sponsor: Capital Medical University | Conditions: Influenza, Influenza Prophylaxis | NA | Status: NOT_YET_RECRUITING